GoodRx is a buy that can surge 60% from here, Citi says

The sell-off in telemedicine name GoodRx is overdone, and now is a good time to buy…

Sell Ally Financial as shares could fall nearly 30% from here, Morgan Stanley says in downgrade

It’s time for investors to bail on Ally Financial , according to Morgan Stanley. Analyst Betsy…

Stifel downgrades CrowdStrike, says tough macro backdrop is battering cybersecurity stock

It’s time to take a step back from CrowdStrike Holdings after the cybersecurity company’s latest earnings…

Blackstone is a top pick in financials ahead of a potential Fed pivot, Morgan Stanley says

It’s time to buy Blackstone as investors prepare for a pivot from the Federal Reserve, according…

Roku’s ‘lack of profitability’ justifies a discount to its peers, KeyBanc says in downgrade

Roku faces a challenging road to profitability, according to KeyBanc Capital Markets. The firm downgraded shares…

JPMorgan downgrades DraftKings, says other sports betting stocks look more attractive

It’s time for investors to ditch shares of DraftKings , according to JPMorgan. Analyst Joseph Greff…

Cowen upgrades Walgreens, says stock can rally more than 30% as company grows health care business

Shares of Walgreens Boots Alliance offer an attractive risk-reward to investors as the company transforms into…

Buy Conagra as it catches up with the competition, UBS says in upgrade

It’s time to buy Conagra as it catches up to its rivals, according to UBS. Analyst…

Sell this medical testing stock poised to fall more than 15% from here, Citi says in downgrade

It’s time for investors to sell shares of Quest Diagnostics , according to Citi. Analyst Patrick…

Deutsche makes ‘leap-of-faith’ upgrade to Walgreens, says stock could rally 30%

Walgreens could stand to benefit from recent business moves if they are executed well, Deutsche Bank…

JPMorgan says this railroad stock is a top pick, citing strength in grain shipments

Canadian Pacific will gain momentum through the fourth quarter at a time when many companies are…

Piper Sandler upgrades Array Technologies, says solar stock can surge on improved forward outlook

Solar stock Array Technologies has outperformed this year, and Piper Sandler thinks there’s even more upside…

Buy this niche health care tech leader as pharmacies shift toward automation, Bank of America says

It’s a good time for investors to stock up on shares of Omnicell as the pharmacy…

Deutsche Bank upgrades Moderna, says strong second-quarter results set up the stock for big gain ahead

Strong second-quarter results from Moderna make now an opportune time to buy shares of the biotechnology…

Goldman says buy this ground-breaking biotech stock poised to rally 75% from here

Now is the time to buy biotech company Kymera Therapeutics , as shares could jump more…

Exchange operator Cboe is a buy as recession chances rise, Morgan Stanley says

As the risk of a recession continues to rise, Morgan Stanley believes it’s time to buy…

Bernstein calls medical tech company Dexcom a clear buy, citing a long-term runway for diabetes management

Medical tech company Dexcom is primed for big gains ahead, Bernstein said Friday. The firm initiated…

Bank of America upgrades Goldman Sachs, says it will thrive in the coming economic storm

Investors looking to protect themselves from an economic slowdown should put their money in Goldman Sachs…

JPMorgan upgrades Snowflake, says stock can rally 30% from here

There could be some big gains ahead for Snowflake, JPMorgan said Thursday. The firm upgraded the…

Palantir is a buy as demand for AI platforms grows, Bank of America says

The shine has came off of Palantir in recent months, but the defense tech company’s growth…